Biogen Canada is a biopharmaceutical company principally engaged in discovering and developing drugs for human health care through treating the underlying cause of a disease. Canadian Headquarters are in Mississauga , Ontario . The Company’s revenues are generated from international sales of AVONEX® (Interferon beta-la), the leading biologic treatment for Multiple Sclerosis in the world, and from the worldwide sales by licensees of a number of products, including alpha interferon and hepatitis B vaccines and diagnostic products. Biogen is currently developing AMEVIVE™ (alefacept), a selective immunomodulating agent for the treatment of patients with moderate to severe Psoriasis who are candidates for photo or systemic therapy. Biogen’s research and development activities are focused on novel products to treat inflammatory and autoimmune diseases such as Psoriasis.
- 2017 Fall Program
- Contact Us